NGS for diagnostic

NGS for diagnostic

High-throughput DNA sequencing (Next Generation Sequencing or NGS) provides considerable potential for knowledge of the human, bacterial or viral genome.
Next Generation Sequencing (NGS) technology is being rapidly integrated into clinical laboratory tests. Current applications include the detection of germline variants in inherited diseases, somatic variants in cancers, circulating free cellular DNA subpopulations and unique viral or microbial genomes in metamicrobial infections or genomes in normal human flora or altered.
The advantage of using NGS in diagnosis is the introduction of testing of many genes in both a relatively short time and relatively low cost, resulting in more molecular diagnostics.
Because cancer is a genetic disease caused by inherited or somatic mutations, new DNA sequencing technologies can be applied to the detection, management, and treatment of the disease.

SNPXplex® Kit - For identity vigilance in NGS diagnostics
SNPXPlex, a simple and rapid barcoding technique for NGS diagnostic identity vigilance

El panel ONCOTARGETes una combinación de 1229 sondas diferentes, repartidas entre las secuencias codificantes de 10 oncogenes de interés, vinculados a una autorización de comercialización para oncoterapia, así como el gen TP53 (véase el cuadro).  El kit ONCOTARGET se ha desarrollado para proporcionar una respuesta rápida y fiable a partir de todo tipo de muestras humanas, con el fin de ayudar...

LymphoSign Test-Kit : A fine classification of non-Hodgkin's lymphomas
LymphoSign Kit  Helps to establish an accurate diagnosis and treatment plan for non-Hodgkin's lymphoma   Non-Hodgkin's lymphoma is a type of cancer that originates in the lymphatic system, which is part of the immune system. It is characterized by the abnormal growth of lymphocytes, a type of white blood cell, and can occur in any part of the body. There are more than 80 types of non-Hodgkin's lymphoma, some of which are rare and difficult to characterize...

 Sarcoma diagnostic in a single reaction
     SarcomaFusion Test A unique test, based on a patented ligation-dependent PCR technology   Fusion transcripts are frequently observed in around 1/3 of soft tissue tumours, and the scientific literature describes more than 140 different fusions. These fusions are often associated with specific histological subtypes and targeted therapies, making them extremely useful molecular diagnostic markers...